Abstract PO1-14-11: Different molecular processes are associated with recurrence in the clinical high- genomic low risk (cH/gL) and clinical low- genomic high risk (cL/gH) groups of the MINDACT clinical trialChristine Desmedt,Ha-Linh Nguyen,François Richard,Marion Maetens,Coralie Poncet, Laura De Meulemeester,Kim Aalders,Mauro Delorenzi,Suzette Delaloge,Jean-Yves Pierga,Etienne Brain,Suzan Vrijaldenhoven,Peter A Neijenhuis,Emiel Rutgers,Florentine Hilbers,Laura Van ’t Veer,Giuseppe Viale,Christos Sotiriou,Martine Piccart,Fatima CardosoCancer Research（2024）引用 0|浏览37暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
